Article info

Download PDFPDF

Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy

Authors

  1. Correspondence to Dr Andrew Lloyd, Acaster Lloyd Consulting, London W2 6LG, UK; andrew.lloyd{at}acasterlloyd.com
View Full Text

Citation

Lloyd A, Piglowska N, Ciulla T, et al
Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy

Publication history

  • Received August 16, 2018
  • Revised December 20, 2018
  • Accepted December 20, 2018
  • First published January 18, 2019.
Online issue publication 
October 23, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.